EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

A comparative study of proliferating borderline and invasive epithelial ovarian tumors in young women






Australian & New Zealand Journal of Obstetrics & Gynaecology 29(3 PART 1): 245-249

A comparative study of proliferating borderline and invasive epithelial ovarian tumors in young women

A series of 18 patients with proliferating or borderline ovarian tumours and 18 with invasive ovarian tumours is discussed. Proliferating tumours occurred at a younger mean age than invasive disease, and presented at an earlier stage, both contributing factors to their more favourable outlook. Histopathological assessment revealed that the majority of both proliferating and invasive tumours were of serous origin. Mucinous cell type occurred less often as did the endometrioid and clear cell type. The management of the proliferating tumours involved 'radical' surgical procedures in 11 of 18 (61.6%) patients. Only 7 patients (38.8%) had conservative surgical procedures performed. Six patients (33%) had adjuvant chemotherapy while 2 (11%) also underwent abdominopelvic irradiation. All patients with invasive disease had radical surgery and adjuvant chemotherapy and 2 also received abdominopelvic irradiation. The fact that epithelial malignancies of the ovary do occur in younger women needs to be remembered by gynaecologists contemplating surgical procedures on younger patients with adnexal masses. Proliferating or borderline tumours tend to occur more frequently in the younger age groups, and contrary to the implication of their name, they are associated with significant morbidity and mortality.

(PDF 0-2 workdays service: $29.90)

Accession: 006936029

PMID: 2604656



Related references

Borderline and invasive epithelial ovarian tumors in young women. Obstetrics and Gynecology 82(5): 752-756, 1993

Fertility-sparing surgery and outcome in fertile women with ovarian borderline tumors and epithelial invasive ovarian cancer. European Journal of Obstetrics, Gynecology, and Reproductive Biology 134(1): 110-114, 2006

Epidemiologic differences between women with borderline ovarian tumors and women with epithelial ovarian cancer. Gynecologic Oncology 74(1): 103-107, 1999

Risk for invasive and borderline epithelial ovarian neoplasias following use of hormonal contraceptives: the Norwegian Swedish Women's Lifestyle and Health Cohort Study. British Journal of Cancer 90(7): 1386-1391, April 5, 2004

Immunohistochemical study of the expression CD44 in serous, borderline, malign surface epithelial ovarian tumors and metastatic ovarian tumors. 2007

Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors. Oncogene 12(10): 2147-2153, 1996

Prognostic factors in borderline and invasive ovarian tumors of the common epithelial type. Pathology, Research and Practice 182(6): 755-774, 1987

An in vitro study of ovarian atypical proliferating (borderline) serous tumors. International Journal of Gynecological Cancer 2(1): 41-48, 1992

Long-term survival in women with borderline ovarian tumors: a population-based survey of borderline ovarian tumors in Sweden 1960-2007. Acta Obstetricia et Gynecologica Scandinavica 95(4): 473-479, 2016

Detailed deletion mapping of chromosome 17 in human borderline and invasive epithelial ovarian tumors. Proceedings of the American Association for Cancer Research Annual Meeting 36(0): 545, 1995